Sylvie Luce

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study

Abdelbari Baitar, Cindy Kenis, R. Moor et al. · Journal of Geriatric Oncology · 2015 · 57 citations

Nursing, Family Medicine, Geriatric Oncology +11

Comprehensive geriatric assessment and comorbidities predict survival in geriatric oncology

N. Denewet, Sandra De Breucker, Sylvie Luce et al. · Acta Clinica Belgica · 2016 · 36 citations

Health related quality of life in older patients with solid tumors and prognostic factors for decline

Lore Decoster, Chantal Quinten, Cindy Kenis et al. · Journal of Geriatric Oncology · 2019 · 26 citations · Full text

Health Related Quality, Quality Of Life, Life Assessment +12